Abstract
AbstractThis study aimed to analyze the concentrations of VEGF, b-FGF, TNF, interleukin (IL)-1, IL-6, IL-8, IL-10, and IL-12 in the aqueous humor of patients with diabetic macular edema with and without peripheral retinal ischemia and to ascertain the changes in the levels of these molecules during treatment with ranibizumab. A therapeutic, prospective, randomized interventional study was carried out. Twenty-four eyes from 24 patients were studied and divided into 3 groups. Group 1 (9 eyes) included patients with diabetic macular edema without peripheral ischemia. Group 2 (10 eyes) included patients with diabetic macular edema with peripheral ischemia. Group 3 (5 eyes), the control group, included patients without systemic and/or eye diseases. Patients in Groups 1 and 2 received 3 intravitreal injections of 2 mg/0.05 ml ranibizumab at an interval of approximately 30 days. Before administering the injections, the aqueous humor was collected. In the control group, aqueous humor was collected before facetectomy. During treatment, the median IL-6 concentration significantly increased in Group 1 but showed a slight but not significant decrease in Group 2. Interleukin 8 levels were significantly different at the end of treatment compared to the beginning in Groups 1 and 2. TNF, IL-1, IL-10, and IL-12 levels were practically unchanged in both groups. VEGF was significantly reduced at the end of the study in Groups 1 and 2. B-FGF was not detected in most of the studied patients, and in those with detectable levels, there was no significant variation. There was a significant increase in the median level of interleukin 6 in the group without ischemia and a significant decrease in VEGF in both groups. The cytokines TNF, IL-1, IL-10, and IL-12 did not show significant variation.
Funder
No funding existed for this study
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Cheung, N., Mitchell, P. & Wong, T. Y. Diabetic retinopathy. Lancet 376(9735), 124–136 (2010).
2. Klein, R., Klein, B. E. & Moss, S. E. Visual impairment in diabetes. Ophthalmology 91, 1–9 (1984).
3. Nussenblatt, R. B., Kaufman, S. C., Palestine, A. G., Davis, M. D. & Ferris, F. L. 3rd. Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology 94, 1134–1139 (1987).
4. Klein, R. Diabetic retinopathy. Annu Rev Public Health. 17, 137–158 (1996).
5. Romero-Aroca, P. et al. Diabetic macular edema pathophysiology: Vasogenic versus inflammatory. J. Diabetes Res. 2, 2156273 (2016).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献